SCHEMBL8867992

SCHEMBL8867992

CCOCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NC3CCCCC3)cc2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.51
TSHR P16473 3/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
BLM P54132 2/20 0.51
CYP3A4 P08684 1/20 0.51
HTR1A P08908 1/20 0.51
MAPT P10636 1/20 0.51
CYP2C9 P11712 1/20 0.51
NFKB1 P19838 1/20 0.51
CNR1 P21554 1/20 0.51
CYP2C19 P33261 1/20 0.51
ADRA1A P35348 1/20 0.51
KMT2A Q03164 1/20 0.47
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA9 Q16790 1/20 0.46
HTT P42858 1/20 0.45
P4HTM Q9NXG6 2/20 0.45
ALDH1A1 P00352 2/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869950 0.92 LMNA (0.54) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8869631 0.89 P4HTM (0.53) LMNASMN1; SMN2MAPTKMT2AP4HTM
SCHEMBL8868071 0.88 LMNA (0.55) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL7867700 0.87 LMNA (0.45) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8867931 0.87 HPGD (0.51) LMNASMN1; SMN2MAPTKMT2AHTT
SCHEMBL8869818 0.87 LMNA (0.51) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL9139425 0.86 P4HTM (0.44) LMNATSHRSMN1; SMN2BLMCYP3A4
SCHEMBL8868013 0.86 P4HTM (0.50) LMNASMN1; SMN2MAPTKMT2AP4HTM
SCHEMBL8868196 0.86 P4HTM (0.53) SMN1; SMN2MAPTKMT2AP4HTMALDH1A1
SCHEMBL8869667 0.86 P4HTM (0.53) SMN1; SMN2MAPTKMT2AP4HTMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed